Difficulty: Medium
Average Score: 85%
Practice
Patient with +ve history of hepatitis c infection presents with hepatic portalsystemic encephalopathy. Which of the following drugs, given in relatively high doses, would be most suitable for the relief of signs and symptoms of this condition, and the likely underlying biochemical anomalies?
Correct answer
C
Rationale
In this scenario, the correct answer is option C) Lactulose. Lactulose is the most suitable drug for hepatic portal-systemic encephalopathy (HPSE) due to its mechanism of action and therapeutic effects. HPSE is characterized by elevated blood ammonia levels resulting from impaired liver function. Lactulose works by promoting the excretion of ammonia in the feces through acidification of the colon, thus reducing systemic ammonia levels and ameliorating the symptoms of encephalopathy.
Option A) Diphenoxylate is an opioid used to treat diarrhea and would not address the underlying cause of HPSE, which is elevated ammonia levels.
Option B) Lansoprazole is a proton pump inhibitor used to reduce stomach acid production and treat conditions like ulcers and acid reflux. It is not effective in reducing ammonia levels or treating HPSE.
Option D) Loperamide is an antidiarrheal agent that works by slowing down gut motility. While it may help with diarrhea symptoms, it does not address the ammonia buildup seen in HPSE.
From an educational standpoint, understanding the pathophysiology of HPSE and the mechanism of action of drugs is crucial for selecting the most appropriate treatment. Lactulose's unique mechanism of reducing ammonia levels makes it the most suitable option for managing HPSE in patients with a history of hepatitis C infection. This case highlights the importance of matching the drug's mechanism of action with the underlying pathophysiology of the condition for effective treatment outcomes.
Option A) Diphenoxylate is an opioid used to treat diarrhea and would not address the underlying cause of HPSE, which is elevated ammonia levels.
Option B) Lansoprazole is a proton pump inhibitor used to reduce stomach acid production and treat conditions like ulcers and acid reflux. It is not effective in reducing ammonia levels or treating HPSE.
Option D) Loperamide is an antidiarrheal agent that works by slowing down gut motility. While it may help with diarrhea symptoms, it does not address the ammonia buildup seen in HPSE.
From an educational standpoint, understanding the pathophysiology of HPSE and the mechanism of action of drugs is crucial for selecting the most appropriate treatment. Lactulose's unique mechanism of reducing ammonia levels makes it the most suitable option for managing HPSE in patients with a history of hepatitis C infection. This case highlights the importance of matching the drug's mechanism of action with the underlying pathophysiology of the condition for effective treatment outcomes.